New Cancer Genomics Program for Veterans
Military members and veterans with cancer can now access genomic profiling and biomarker interpretation at no cost.
Updated on Oct. 30, 2026 in Cancer
Live Poll
Do you believe the U.S. government provides sufficient specialized cancer healthcare resources to military veterans?
The SOTERIA Precision Medicine Foundation has launched a new program called Cancer Hunt, which provides genomic profiling to military members and veterans with cancer. The service aims to remove financial and institutional barriers for patients by offering testing and biomarker interpretation at no cost.
Why it matters
By providing access to advanced genomic tools, the program seeks to circumvent typical insurance and institutional hurdles that often delay specialized cancer care for military personnel. This effort also focuses on capturing longitudinal data to better understand links between specific military-related exposures and cancer development.
SOTERIA is currently operating as a 501(c)(3) nonprofit to provide genomic profiling and biomarker analysis. While the service is now available to participants, the long-term impact on patient survival outcomes and the definitive connections between specific exposures and cancers remain under study.
The players
SOTERIA Precision Medicine Foundation
A California-based nonprofit organization that provides genomic profiling and biomarker interpretation services to military personnel and veterans.
The details
The Cancer Hunt program functions by utilizing a specialized team consisting of oncology nurse navigators, PhD-level scientists, oncology specialists, and logistics coordinators. These professionals facilitate the collection of patient genomic data alongside longitudinal molecular and exposure information. This integrated approach allows for the interpretation of complex biomarkers while simultaneously building a database to study how environmental or occupational factors during military service contribute to cancer risk.
Timeline
October 29, 2026: SOTERIA announced the launch of the Cancer Hunt program.
Health Landscape
This program builds upon the broader effort to address the long-term health consequences of military service, such as those formally recognized by the PACT Act. It represents a shift toward using precision medicine to identify specific molecular signatures associated with service-related environmental exposures.
Military members or veterans currently navigating a cancer diagnosis may use this resource to access genomic testing without insurance barriers. Patients should consult with their primary oncologist to discuss whether biomarker interpretation is appropriate for their specific diagnosis and care plan.
The takeaway
The Cancer Hunt program offers a new pathway for veterans to access genomic profiling and expert biomarker interpretation at no cost. If you or a loved one are a veteran managing a cancer diagnosis, speak with a physician about whether genomic data could provide additional insights into your care options.
Further reading
To learn more about current diagnostic developments, see the latest updates from Cancer.
Live Poll
Do you believe the U.S. government provides sufficient specialized cancer healthcare resources to military veterans?
